Here are four points:
1. The shares were sold at $52.43 per share for a total value of $308,369.
2. The 50-day moving average price of the shares is $50.24, and the 200-day moving average price is recorded at $50.67.
3. The current rating of the shares is “outperform.”
4. The company has a market cap of $2.56 billion.
More articles on devices:
Cytos Biotechnology and Kuros Biosurgery merge — 6 takeaways
Zacks downgrades Mazor Robotics to ‘hold’ rating: 5 facts
InVivo receives patents for instrument aiding treatment of chronic spine injuries
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.